Pitt Shield

Advanced Search Options

Expand ▼

Search Results

❮❮ 69 70 71 72 73 74 75 ❯❯

3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development.

Authors: Molotkov A, Doubrovin M, Bhatt N, Hsu FC, Beserra A, Chopra R, Mintz A

Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery.

Authors: Oikari LE, Pandit R, Stewart R, Cuní-López C, Quek H, Sutharsan R, Rantanen LM, Oksanen M, Lehtonen S, de Boer CM, Polo JM, Götz J, Koistinaho J, White AR

One-Year Outcome of Multiple Blood-Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma.

Authors: Park SH, Kim MJ, Jung HH, Chang WS, Choi HS, Rachmilevitch I, Zadicario E, Chang JW

Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography.

Authors: Arif WM, Elsinga PH, Gasca-Salas C, Versluis M, Martínez-Fernández R, Dierckx RAJO, Borra RJH, Luurtsema G

Magnetic Resonance Imaging-Guided Focused Ultrasound-Based Delivery of Radiolabeled Copper Nanoclusters to Diffuse Intrinsic Pontine Glioma.

Authors: Zhang X, Ye D, Yang L, Yue Y, Sultan D, Pacia CP, Pang H, Detering L, Heo GS, Luehmann H, Choksi A, Sethi A, Limbrick DD, Becher OJ, Tai YC, Rubin JB, Chen H, Liu Y

Focused Ultrasound Strategies for Brain Tumor Therapy.

Authors: Bunevicius A, McDannold NJ, Golby AJ